{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-005233","form_type":"8-K","ticker":"CNSP","cik":"0001729427","company_name":"CNS Pharmaceuticals, Inc.","filed_at":"2026-07-02T11:30:21+00:00","discovered_at":"2026-07-02T11:35:00.314741+00:00","generated_at":"2026-07-02T11:35:09.438372+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"CNS Pharmaceuticals posts investor presentation; no new material details disclosed","bullets":["Investor presentation posted on company website on July 2, 2026.","Filing includes only cover page and forward-looking statements; no financial or operational data.","No updates on clinical trials, revenue, or guidance provided in this filing.","Full presentation available on company's website."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-005233","json":"https://secwatch.observer/filing/0001683168-26-005233.json","markdown":"https://secwatch.observer/filing/0001683168-26-005233.md","text":"https://secwatch.observer/filing/0001683168-26-005233.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1729427/000168316826005233/0001683168-26-005233-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1729427/000168316826005233/cns_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-02T11:35:09.438372+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}